Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank20
3Y CAGR-50.9%
5Y CAGR-45.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-50.9%/yr
vs -0.8%/yr prior
5Y CAGR
-45.2%/yr
Recent deceleration
Acceleration
-50.2pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $19000.00 | -47.2% |
| 2025 | $36000.00 | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $161000.00 | - |
| 2022 | $0.00 | -100.0% |
| 2021 | $385000.00 | +327.0% |
| 2020 | $90157.00 | -45.8% |
| 2019 | $166250.00 | -84.8% |
| 2018 | $1.09M | +946.0% |
| 2017 | $104556.00 | - |